Approval · Notice of Compliance 7307 · 2005

MINIPRESS: Notice of Compliance 7307

Issued August 22, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 7307
Date: August 22, 2005
Company: Erfa Canada Inc.
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Antihypertensive

Products in this notice

Brand	DIN	Status today
MINIPRESS	00560952	Dormant
MINIPRESS	00560960	Dormant
MINIPRESS	00560979	Dormant

Medicinal ingredients

PRAZOSIN HCL 1 MG per TAB
PRAZOSIN HCL 2 MG per TAB
PRAZOSIN HCL 5 MG per TAB